{
    "2019-12-24": [
        [
            {
                "time": "2018-11-15",
                "original_text": "Biotech Leading in Q4: Best ETFs & Stocks",
                "features": {
                    "keywords": [
                        "Biotech",
                        "Leading",
                        "Q4",
                        "ETFs",
                        "Stocks"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2019-12-20",
                "original_text": "Allergan (AGN) Gets FDA Approval for Migraine Drug Ubrelvy",
                "features": {
                    "keywords": [
                        "Allergan",
                        "FDA",
                        "Approval",
                        "Migraine",
                        "Drug",
                        "Ubrelvy"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}